Compare Datadog Inc (DDOG) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Datadog Inc vs Twist Bioscience Corp — how do they compare? Datadog Inc trades at $271.91 (market cap $97.43B), while Twist Bioscience Corp trades at $158 (market cap $10.32B). The key difference: Datadog Inc is far larger — about 9.4× Twist Bioscience Corp's market cap, and Datadog Inc is trading nearer its 52-week high, Twist Bioscience Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Datadog Inc for 76 Days and Twist Bioscience Corp for 27 Days on average.
| DDOG | TWST | |
|---|---|---|
Market Cap | $97.43B | $10.32B |
Volume | 1,586,926 | 5,894,998 |
Sector | Technology | Health |
52-Week High | $288.15 | $205.00 |
52-Week Low | $102.62 | $25.45 |
Typical Hold Time | 76 Days | 27 Days |
Enterprise Value | $93.72B | $10.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Datadog (DDOG) trades at $273.8, down 1.6% on the day, yet maintains a bullish technical stance with strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth remains robust, climbing from $1.7B in 2022 to $3.4B in 2025, though net income margins are volatile. Positive sentiment is fueled by AI-driven demand and global expansion, as highlighted in recent financial media.
The outlook is cautiously optimistic given high valuation multiples (P/E 542.68) and negative net cash flow, but strong revenue growth and a dominant buy rating consensus (83.34%) suggest upside to the $276.10 price target. Key risks include competitive pressures and reliance on enterprise cloud spending cycles.
TWST trades at $152.05, down 8.94% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $376.57 million in 2025, but profitability remains elusive with a net income margin of -31.66%. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, providing a potential growth catalyst amid ongoing losses.
The outlook is mixed; analyst consensus is bullish with a $145.20 price target, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on the company's ability to monetize its AI collaborations and achieve profitability, while downside risks include cash burn and competitive pressures in the biotech sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Datadog Inc
Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered as software-as-a-service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of different applications throughout their businesses.
Read more on DDOG →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
